首页/数据集/Supplementary Table S3 from Phase I/II Trial of Vemurafenib in Dogs with Naturally Occurring, <i>BRAF</i>-mutated Urothelial Carcinoma

Supplementary Table S3 from Phase I/II Trial of Vemurafenib in Dogs with Naturally Occurring, <i>BRAF</i>-mutated Urothelial Carcinoma

NIAID Data Ecosystem2026-04-30 收录

尿路上皮癌

蛋白激酶磷酸化位点

数据链接：

https://figshare.com/articles/dataset/Supplementary_Table_S3_from_Phase_I_II_Trial_of_Vemurafenib_in_Dogs_with_Naturally_Occurring_i_BRAF_i_-mutated_Urothelial_Carcinoma/22522854 数据链接链接失效反馈

官方服务：

资源简介：

Protein kinases phosphosites

应用场景：

创建时间：

2021-11-01

尿路上皮癌

机器学习

Additional file 3: Supplementary Table 1. Patient characteristics of the training cohort. Supplementary Table 2. Characteristics of the UTUC validation cohort. Supplementary Table 3. Characteristics o

DataCite Commons2024-02-07 更新80

Table_1_Novel T-cell signature based on cell pair algorithm predicts survival and immunotherapy response for patients with bladder urothelial carcinoma.xlsx

尿路上皮癌

预后预测

BackgroundT-cell–T-cell interactions play important roles in the regulation of T-cells’ cytotoxic function, further impacting the anti-tumor efficacy of immunotherapy. There is a lack of comprehensive

frontiersin.figshare.com2023-06-21 更新40

Comparative efficacy and safety of PD-1/PD-L1 Inhibitors versus platinum-based chemotherapy for the first-line treatment of advanced uroepithelial cancer: a systematic review and network meta-analysis

尿路上皮癌

PD-1/PD-L1抑制剂疗效评估

Advanced uroepithelial carcinoma is a malignant tumour with high aggressiveness and recurrence tendency, which has a serious impact on the survival rate and quality of life of patients. Platinum-based

NIAID Data Ecosystem20

Targeted sequencing data of ARID1A in UC patients

尿路上皮癌

靶向测序

We analyzed data from over 600 patients and demonstrated that the combination of ARID1A loss and high CD8 + T cell infiltration defines a distinct subgroup of urothelial carcinoma (UC) with

Figshare2025-07-11 更新60

Table_3_The MicroRNA Prediction Models as Ancillary Diagnosis Biomarkers for Urothelial Carcinoma in Patients With Chronic Kidney Disease.XLSX

miRNA生物标志物

尿路上皮癌

Urothelial carcinoma is a common urological cancer in chronic kidney disease patients. Cystoscopy and urine cytology are the clinical diagnostic tools for UC. However, cystoscopy is an invasive proced

NIAID Data Ecosystem30

Supplementary Table S3 from Phase I/II Trial of Vemurafenib in Dogs with Naturally Occurring, <i>BRAF</i>-mutated Urothelial Carcinoma

资源简介：

相关数据集